Invest in something good
Invest in something good
PetVivo Holdings, Inc. (NASDAQ: PETV) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals.
Earnings webcast replay
Watch as PetVivo Holdings, Inc. announces the recent annual earnings report via webcast.
Why invest with PetVivo?
Spryng™ with OsteoCushion™ Technology is within a booming industry that continues to increase in growth, need, and sales.
Osteoarthritis market
Osteoarthritis (OA) affects 1 out of 4 dogs and over half of all horses. This is an addressable opportunity in companion animal OA therapeutics market. U.S. veterinary care and product estimated sales in 2021 was $11B.
Pet ownership
Pets are a notable part of the cultural landscape, with 70% of US households owning a pet. In the US there are 69M dogs and approximately 7.2M horses.
Pet market
US pet spend increased from $103.6B in 2020 to $123.6B in 2021.
Positioned to scale
PetVivo’s new facility, positioned to scale, has capacity to produce up to 500K units annually, equalling up to $100M in revenue.
Strong product pipeline
With a robust pipeline of 17 products at different stages of development and commercialization, PetVivo’s strategy focuses on veterinary medical devices which do not require FDA premarket approval, creating a faster path to market.
View our corporate goals and product pipeline.
Review our SEC filing documents and information.
PetVivo Holdings, Inc. is a publicly-traded company on NASDAQ: PETV.
Review our Diversity Matrix.
View Upstream Dual Listing Information
Corporate Governance
View our Audit Committee Charter.
View our Compensation Committee Charter.
View our Nominating and Governance Committee Charter.
Code of Business Conduct and Ethics
